Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy supporting the ...

To verify the clinical benefit of VOCERYQ, a confirmatory study is expected to be conducted. The FDA requires INOVIO to ...

Sheboygan's Mead Public Library will offer a free live VHS show Nov. 6 and the second annual Sheboygan Zine Fest Nov. 7.

California regulators adopted a controversial plan changing how the state governs the pumping of water in the Sacramento-San ...

Hidden mechanisms in extracellular DNA spotted by researchers at Aarhus University enable dormant viruses to become ...

Traditional speech-language therapy for people who stutter has largely operated under a medical model focused on eliminating ...

Israel's Supreme Court ruled that exploiting a coding flaw can count as computer intrusion, even when the software allowed ...

Across the West, ranchers are finding that the best defense against catastrophic wildfire isn’t suppression — it’s learning ...

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a biotechnology company developing treatments ...

In a head-to-head trial, participants with type 2 diabetes lost more than twice as much weight with retatrutide as with Ozempic and had a greater reduction in A1c.

FIS supports about 600 recordkeepers and the millions of savers they serve. Brian Nicholson and Harshad Joshi of FIS explain how the FIS Retirement Platform (FRP) was rebuilt for the cloud, how it ...

Many have voiced concerns that artificial intelligence will take jobs away from humans. But assistant professor of chemistry ...